How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,222 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

6101. A Patient-Centered Approach to Improve Screening for Side Effects of Second Generation Antipsychotics (SGAs)

Posted : September 12, 2014 Last Update Posted : April 27, 2015 Sponsor: US Department of Veterans Affairs Information provided by (Responsible Party): VA Office of Research and Development ( US Department of Veterans Affairs ) Study Details Study Description Go to Brief Summary: The purpose of this study is to determine if individuals with serious mental illnesses exposed to a patient-centered computerized tool versus printed educational materials have higher rates of screening for the metabolic (...) side effects of second-generation antipsychotic medications and different patterns of communication with their prescribers about screening. Condition or disease Intervention/treatment Phase Schizophrenia Psychotic Disorders Behavioral: Patient-centered computerized tool Behavioral: Written educational materials Not Applicable Detailed Description: Project Background/Rationale: Second-generation antipsychotic (SGA) medications are widely used to treat psychotic disorders but are associated

2008 Clinical Trials

6102. Evaluation of an Intimate Partner Violence Screening-Intervention

, 2004 Actual Primary Completion Date : October 15, 2005 Actual Study Completion Date : October 15, 2005 Arms and Interventions Go to Arm Intervention/treatment Experimental: Screening and Intervention Use a computer-based screening tool for intimate partner violence and provide a multi-faceted intervention based on the needs of the woman and services should would like to utilize. Other: Screening and Intervention Screening for intimate partner violence and providing a multi-faceted intervention (...) which depends on the needs of the patient Active Comparator: Usual Care Use a computer-based screening tool for intimate partner violence and provide list of resources available. Also, all physicians were trained on intimate partner violence and were told they could help anyone regardless of randomization. Other: Usual Care Screening for intimate partner violence and provide enhanced usual care which includes providing resource list, educating medical staff and partner violence and instructing

2005 Clinical Trials

6103. Measuring sensorineural disability in preterm children using a public health screening strategy: a randomised controlled trial. (Abstract)

to receive the preterm-targeted or NHMRC programme. Primary outcome, correct identification of neurosensory disability by general practitioners assessed against gold standard paediatric assessments. Sensitivity analysis estimated interrater agreement and screening accuracy. Secondary outcomes, post natal depression (PND), parental stress, health service use, screening programme helpfulness and correct identification of levels of disability severity.Of the 195 infants with data on the primary outcome (...) identification of disability status compared to the NHMRC universal programme (Australian New Zealand Clinical Trails Registry number, ACTRN 12606000472572); however (ii) it did demonstrate greater efficacy as a screening tool in accurately identifying disabled children.

2008 Journal of paediatrics and child health Controlled trial quality: predicted high

6104. Validation of the 7-Minute Screen for the Detection of Early-Stage Alzheimer's Disease. (Abstract)

-stage AD and healthy control subjects.Sixty-three patients who were diagnosed as having probable or possible AD and 91 community-dwelling elderly individuals of comparable age, sex distribution, and education were administered the 7MS (paper-and-pencil version) and other screening batteries. All patients were rated Clinical Dementia Rating (CDR) 0.5-1, categorized as early-stage AD, and all participants obtained a score of less than 6 for the Geriatric Depression Scale (15-item version).Mean scores (...) effects (age, sex, and education) were not significantly associated with the total score of the 7MS in controls.The results showed that the 7MS had a high level of sensitivity and specificity. We also found that the 7MS was not affected by demographic characteristics. These findings demonstrated that the 7MS is a useful screening tool for discriminating patients with early-stage AD from intact individuals.Copyright 2008 S. Karger AG, Basel.

2008 Dementia and Geriatric Cognitive Disorders

6105. Validation of the Mood Disorder Questionnaire for screening for bipolar disorder in a UK sample. (Abstract)

) with specificity 0.86. The optimal cut-off score in the current sample was a score of 9 or more endorsed symptoms without applying the supplementary questions (sensitivity of 0.90 and 0.88 for bipolar I and bipolar II groups respectively with a specificity of 0.90).The sample was drawn from a tertiary mood disorders clinic.The MDQ appears to be a useful screening tool for bipolar spectrum disorder in UK psychiatric practice with sensitivity for bipolar II disorder improved by dropping the supplementary (...) Validation of the Mood Disorder Questionnaire for screening for bipolar disorder in a UK sample. The Mood Disorder Questionnaire (MDQ) was designed as a screening questionnaire for bipolar disorder. Previous research has raised questions about the suitability of the MDQ structure for screening for bipolar II disorder. This study investigated the optimal sensitivity and specificity cut-off thresholds for the MDQ in bipolar I and bipolar II patients in a UK sample.The MDQ was administered

2008 Journal of Affective Disorders

6106. An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population. (Abstract)

a sensitivity of 0.938 and a specificity of 0.847. At a cut-off of 4, the HADS-D gave a sensitivity of 0.864 and a specificity of 0.788.The GDS-15 and HADS are valid screening tools for detecting depression in aged CHF out-patients. However, use of the HADS requires reduced cut-points to ensure that patients with mood disorder are not missed in this population.Copyright 2007 John Wiley & Sons, Ltd. (...) An evaluation of two self-report screening measures for mood in an out-patient chronic heart failure population. To examine the criterion validity of the Hospital Anxiety and Depression Scale (HADS) and the Geriatric Depression Scale 15-item (GDS-15) in a community sample of Chronic Heart Failure (CHF) out-patients.Eighty-eight of 203 older adults with confirmed CHF responded to a postal survey and participated in a face-to-face interview. The GDS-15 and HADS were compared to diagnoses from

2007 International Journal of Geriatric Psychiatry

6107. Screening for generalized anxiety disorder in geriatric primary care patients. (Abstract)

Screening for generalized anxiety disorder in geriatric primary care patients. To compare two brief screening measures as tools for detecting generalized anxiety disorder (GAD) among older primary care patients.Receiver operating characteristic curve analysis was used to compare the Hospital Anxiety and Depression Scale (HADS) and the Brief Symptom Inventory-18 (BSI-18) against GAD diagnoses obtained from a structured diagnostic interview.The HADS Anxiety subscale was the only measure

2007 International Journal of Geriatric Psychiatry

6108. A statewide screening of mental health symptoms among juvenile offenders in detention. Full Text available with Trip Pro

the computerized version of the Massachusetts Youth Screening Instrument Version 2 (MAYSI-2) 24 to 48 hours after their arrival at detention centers throughout Pennsylvania.Approximately 70% of the males and 81% of the females scored above the clinical cutoff on at least one of the following five MAYSI-2 scales: Alcohol/Drug Use, Angry-Irritable, Depressed-Anxious, Somatic Complaints, and/or Suicide Ideation. Girls were more likely than boys to exhibit internalizing as well as externalizing problems. Mental (...) health problems were most prevalent among white youths and least prevalent among African American youths. When youths repeated the screen upon subsequent visits to detention, their scores generally remained stable.The findings suggest that the MAYSI-2 is a promising triage tool for emergent risk. The use of such a screen may reduce bias in allocation of treatment resources and improves our understanding of the nature of mental health problems in delinquent populations.

2004 Journal of the American Academy of Child and Adolescent Psychiatry

6109. The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. Full Text available with Trip Pro

, and the Anxious/Depressed and Attention problems scales predicted anxiety disorders.These results extend to a paediatrically referred population with previously reported findings in psychiatric samples documenting good convergence between structured interview diagnoses and syndrome congruent CBCL scales. These findings support the utility of the CBCL as a screening tool for the identification of psychiatric comorbidity in ADHD youth in the primary care setting. (...) The CBCL as a screen for psychiatric comorbidity in paediatric patients with ADHD. To examine the informativeness of the Child Behavior Checklist (CBCL) as a screening tool to identify comorbid and non-comorbid cases of attention deficit hyperactivity disorder (ADHD) in a paediatrically referred population. It was hypothesised that specific scales of the CBCL would help identify specific comorbidities within ADHD cases in the primary care setting.The sample consisted of children and adolescents

2005 Archives of Disease in Childhood

6110. The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease. (Abstract)

The Luebeck interview for psychosocial screening in patients with inflammatory bowel disease. Psychosocial factors play an important role in the course of inflammatory bowel disease (IBD). However, a simple, valid psychosocial screening instrument that is suitable for short patient-physician contacts does not exist. Therefore, the Luebeck semistructured Interview for Psychosocial Screening was developed as a rating tool for psychosocial stress in IBD patients (LIPS-IBD).The entire interview (...) . It was found to be a suitable instrument for daily clinical routine. It is potentially a valuable screening tool to obtain reliable, valid, and useful information in daily practice in IBD treatment settings.

2007 Inflammatory Bowel Diseases

6111. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. (Abstract)

A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. To evaluate retinal function in patients on hydroxychloroquine using multifocal electroretinography.A retrospective chart review was performed for 23 patients (46 eyes) on hydroxychloroquine therapy and referred for multifocal electroretinogram (mfERG) testing. Duration of treatment, daily hydroxychloroquine dose, visual acuity, fundus examination, color vision testing, Amsler grid testing (...) pattern observed within each region.Ninety-two regions were assessed for response amplitudes, 31 of which showed a depressed response amplitude. Of the 17 eyes which had at least one region with a depressed response amplitude, clinical examination findings were relatively benign. Color difference plot scoring showed strong agreement with response amplitude, with a Color Difference Plot Scoring System score of 2 or 3 showing 93.55% sensitivity and 60% specificity for a depressed response amplitude

2008 Retina

6112. Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS). (Abstract)

depression, persistent depressive disorders).The results suggest that simple instruments can be used as feasible tools in the screening of mood and anxiety disorders among cancer patients. (...) Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS). The assessment of mood and anxiety disorders secondary to cancer by using easy-to-administer instruments has been the object of recent research.The aim of this study was to examine the accuracy of the short screening tool developed by the National Comprehensive Cancer Network Clinical

2008 Journal of Affective Disorders

6113. Usefulness of the nurse-assisted screening and psychiatric referral program. (Abstract)

it with usual practice.The program consists of two stages. In the first stage, consecutive patients newly admitted to the Oncology/Hematology Unit are administered the Distress and Impact Thermometer (DIT) by nurses as a brief screening tool for major depression and adjustment disorders. In the second stage, the nurses recommend psychiatric referral to patients with scores above the cutoff point. Patients' records were reviewed for a 3-month period before the start of the program and during the 3-month (...) Usefulness of the nurse-assisted screening and psychiatric referral program. Major depression and adjustment disorders are common psychiatric disorders in patients with cancer, but they are often overlooked in clinical oncology settings. The nurse-assisted screening and psychiatric referral program (NASPRP) has been introduced in clinical practice to facilitate psychiatric treatment for major depression and adjustment disorders. This study assessed the usefulness of the NASPRP and compared

2005 Cancer

6114. Pediatric emergency medicine physicians' current practices and beliefs regarding mental health screening. Full Text available with Trip Pro

complaint was psychiatric in nature. The remaining 217 physicians most commonly screened for depression (83%), suicidality (76%), and substance abuse (67%). Only 9% of physicians stated that they used evidence-based medicine in determining their screening practices. Women physicians (odds ratio, 1.94; 95% confident interval, 1.08-3.47) and those using evidence-based medicine (odds ratio, 3.88; 95% confidence interval, 1.92-7.85) were more likely to conduct screening. Significant limitations to screening (...) identified by respondents include the following: time limitations (93%), absence of a validated screening tool (62%), limited resources (46%), and lack of training (44%). Eighty-eight percent of physicians believe that a validated and standardized screening tool would improve their ability to identify PMI.Routine PMI screening is conducted infrequently by most PEM physicians. Improved physician education/training and the development of a validated ED-specific mental health screening tool would assist PEM

2007 Pediatric Emergency Care

6115. Development of a brief mental health screen for intimate partner violence victims in the emergency department. Full Text available with Trip Pro

department to screen IPV victims for depressive symptoms, posttraumatic stress disorder (PTSD) symptoms, and suicidal ideation.The authors conducted a pretest/posttest validation study of female IPV victims to determine what questions from the Beck Depression Inventory II, Posttraumatic Stress Diagnostic Scale, and Beck Scale for Suicide Ideation would predict moderate to severe levels of depressive symptoms, PTSD symptoms, and suicidal ideation. A principal components factor analysis was conducted (...) to determine which questions would be used in the brief mental health screen. Scatter plots were then created to determine a cut point.Scores on the brief mental health screen ranged from 0 to 8. A cutoff score of 4 was used, which resulted in positive predictive values of 96% for the brief mental health screen for depression, 84% for PTSD symptoms, and 54% for suicidal ideation. In particular, four questions about sadness, experiencing a traumatic event, the desire to live, and the desire to commit

2007 Academic Emergency Medicine

6116. Screening for Cognitive Impairment

. 2008 Oct20(5):911-26. Epub 2008 Jun 5. ; Cognitive Tests to Detect Dementia: A Systematic Review and Meta-analysis. JAMA Intern Med. 2015 Sep175(9):1450-8. doi: 10.1001/jamainternmed.2015.2152. ; Screening and case finding tools for the detection of dementia. Part I: Am J Geriatr Psychiatry. 2010 Sep18(9):759-82. ; Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015 Mar 53 (...) Screening for Cognitive Impairment Screening for Cognitive Impairment. Find Screening... | Patient TOPICS Try our Symptom Checker TREATMENT RESOURCES Try our Symptom Checker PROFESSIONAL Upgrade to Patient Pro / / Search Screening for Cognitive Impairment Authored by , Reviewed by | Last edited 28 Jan 2016 | Certified by This article is for Medical Professionals Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research

2008 Mentor

6117. Study of Treatments for Depression Among Displaced Adolescents in Northern Uganda.

and that it is effective in treating depression. Furthermore, our ethnographic work has resulted in a suitable measure for assessing emotional and behavioral problems in war- affected Acholi youth living in the Northern Uganda for use in screening adolescents into intervention groups. The application of valid instruments to assess psychosocial problems and the degree of impairment both pre and post- intervention will be invaluable to our implementing partners - World Vision/War Child - for developing effective (...) interventions to address the ongoing mental health needs of the young people they serve in Northern Uganda. Specific Objectives 1. To assess symptoms of locally described depression-like syndromes (Kumu/Par/Two Tam), a local anxiety syndrome (Ma Lwor) and social problems (Gin lugero/tic marac) in Acholi war-affected adolescents using the Acholi Psychosocial Assessment Instrument (APAI), a locally-derived tool for assessment of emotional and behavioral problems in children and youth available in the Luo

2006 Clinical Trials

6118. Use of Conversation and Acoustic Signals in Measuring Depression Severity

Medical Center Study Details Study Description Go to Brief Summary: The purpose of this study is to test a new monitoring technology that uses the sound of a depressed person's speech to assess the severity of depression symptoms. The Vocal Social Signals Platform (VSSP) is software that analyzes the non-verbal characteristics of a person's speech. This study will test this software to see if it could be a useful measurement tool for assessing depression symptoms. Participation in this study requires (...) as this is a reliability/validity study of a measurement tool. In order to evaluate this technological measure for its psychometric properties, we will recruit 60 subjects recently diagnosed with depression. We will recruit only recently diagnosed patients to maximize the likelihood of the person improving their depressive severity during our study. Even though subjects will be referred by their clinicians as depressed patients we will use CES-D or Centers for Epidemiological Studies Depression Scale to to confirm

2008 Clinical Trials

6119. Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients

rated from 1 (very much improved) to 7 (very much worse). The investigator rated the patient's overall improvement relative to baseline, whether or not, in the opinion of the investigator, this was entirely due to the drug treatment. Change From Baseline in GDS Total Score After 8 Weeks of Treatment [ Time Frame: Baseline and Week 8 ] The Geriatric Depression Scale (GDS) is a patient self-rating scale designed for the screening of depression in the elderly. It has also been validated as a measure (...) Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration

2008 Clinical Trials

6120. Nexalin Therapy for the Treatment of Depressive Symptoms

Summary: The primary objectives of this Phase II study are to demonstrate the safety of Nexalin Therapy and to investigate the efficacy of Nexalin Therapy. Condition or disease Intervention/treatment Phase Depression Device: Nexalin 1.3mA Device Device: Nexalin 15mA device Drug: placebo device and Citalopram Phase 2 Detailed Description: This randomized, double-blind, placebo-controlled, multi-center trial has 3 different treatment arms. Study Tools: Hamilton Depression Rating Scale (HAM-D21) Clinical (...) days off) Daily receipt of a a SSRI (Citalopram or similar) Other Name: Nexalin Device Outcome Measures Go to Primary Outcome Measures : Hamilton Depression Rating Scale (HAM-D21) [ Time Frame: Screening; Baseline; Treatments 5, 10, & 15; Follow-up Weeks 2, 4, 8, & 12 ] Secondary Outcome Measures : Clinical Global Impression (CGI) [ Time Frame: Screening; Baseline; Treatments 5, 10, & 15; Follow-up Weeks 2, 4, 8, & 12 ] Montgomery-Asberg Depression Rating Scale (MADRS) [ Time Frame: Screening

2008 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>